Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
Max Hodak, the former president and co-founder of Neuralink, detailed onstage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Covered in this story
Call it yourself
No calls on $TILE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Interface Inc →Summary aggregated from TechCrunch's public RSS feed. The full reporting belongs to TechCrunch — please read it on their site.